Rock Springs Capital Management LP Q3 2023 Filing

Filed November 14, 2023

Portfolio Value

$3.7B

Holdings

120

Report Date

Q3 2023

Filing Type

13F-HR

All Holdings (120 positions)

#	Stock	Shares	Value	% Portfolio
101	SYREAEGLEA BIOTHERAPEUTICS INC	136,556	$1.7M	0.04%
102	NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC	1,000,000	$1.5M	0.04%
103	CYPHLEAP THERAPEUTICS INC	1,074,517	$1.5M	0.04%
104	SLRNACELYRIN INC	141,876	$1.4M	0.04%
105	FATEFATE THERAPEUTICS INC	612,215	$1.3M	0.03%
106	CGENCOMPUGEN LTD	1,289,990	$1.2M	0.03%
107	—THESEUS PHARMACEUTICALS INC	437,329	$1.2M	0.03%
108	DSGNDESIGN THERAPEUTICS INC	460,391	$1.1M	0.03%
109	—VINCERX PHARMA INC	891,719	$901K	0.02%
110	—KINNATE BIOPHARMA INC	405,811	$568K	0.02%
111	NVRO 2.75 04/01/25NEVRO CORP	500,000	$472K	0.01%
112	NKTXNKARTA INC	331,571	$461K	0.01%
113	DP8CERVOMED INC	80,033	$370K	0.01%
114	NVTA1EURINVITAE CORP	585,659	$354K	0.01%
115	TLPHACELRX PHARMACEUTICALS INC	316,460	$184K	0.00%
116	OVASUSDTEMPEST THERAPEUTICS INC	536,214	$163K	0.00%
117	BCELATRECA INC	362,530	$95K	0.00%
118	SPROSPERO THERAPEUTICS INC	57,373	$69K	0.00%
119	—GAMIDA CELL LTD	52,015	$54K	0.00%
120	NUVB/WSNUVATION BIO INC	134,028	$13K	0.00%

PreviousPage 2 of 2